Wussten Sie, dass in Deutschland rund 9 Millionen Menschen von einer chronischen Nierenkrankheit (chronic kidney disease, CKD) betroffen sind? Tendenz steigend. Dabei wissen 9 von 10 Betroffenen nichts von ihrer Erkrankung. Denn fehlende oder unspezifische Symptome in frühen Stadien der CKD führen dazu, dass die Krankheit oft unentdeckt bleibt. Dabei besteht dringender Handlungsbedarf: Laut der Studie InsideCKD nimmt die Anzahl der CKD-Patient:innen mit einer fortgeschrittenen Erkrankungsform zu und folglich werden immer mehr Menschen auf eine Nierenersatztherapie wie Dialyse oder Transplantation angewiesen sein. Das ist für die Betroffenen mit erheblichen Einschränkungen und Belastungen verbunden. Stellen Sie sich vor, Sie müssten dreimal die Woche für mehrere Stunden zur Dialyse, extreme Ernährungsvorgaben einhalten oder warten jahrelang auf eine Spenderniere. Hinzu kommen hohe Kosten für das Gesundheitssystem. InsideCKD prognostiziert eine Steigerung der jährlichen Gesundheitskosten bis 2027 um 11,9 % auf 10,01 Milliarden Euro. Was dabei besonders ins Gewicht fällt: Die Nierenersatztherapien werden über die Hälfte dieser Kosten ausmachen, obwohl sie nur bei 5,4 % der CKD-Patient:innen indiziert sein werden. Eine frühzeitige Diagnose und Therapieeinleitung ist unabdingbar, um das Fortschreiten der Erkrankung zu verlangsamen und die Dialysepflichtigkeit hinauszuzögern. Wir von #AstraZenecaGermany möchten für die chronische Nierenkrankheit sensibilisieren, Risikogruppen aufklären und die steigende Anzahl an Betroffenen im täglichen Umgang mit der Krankheit unterstützen. Mehr zur chronischen Nierenkrankheit und unserem Engagement finden Sie auf Gemeinsam stark bei chronischer Nierenschwäche (www.teamniere.de) #AstraZenecaGermany #chronischeNierenkrankheit #Niereninsuffizienz #CKD #Nephrologie #GesundheitsCheckup #Diabetes #Herzschwäche #Herzinsuffizienz
Beitrag von AstraZeneca
Relevantere Beiträge
-
By better understanding the interconnections between cardiovascular, renal and metabolic (CVRM) diseases, we can pioneer earlier detection and more effective care management. Diagnosing and managing these diseases promptly can ultimately protect vital organs. Learn more about our approach to transforming care for CVRM diseases: https://learn.az/6044jr0H6
-
Are you a passionate young leader working at the nexus of health and climate change? Or know someone who is? 🌍 We’re partnering with the AFS Youth Assembly to help create a healthier, more sustainable future for people, society and the planet by offering scholarships for young leaders from around the world to join the 2024 AFS Youth Assembly. Apply here: https://learn.az/6045jqSEB #YoungHealthProgramme #YA29 #ChangeMakers
-
Eight million women may be lost to ovarian cancer by 2050 and a significant number of families, friends, communities, workplaces, and society in general will be impacted if nothing changes.1 Our ambition is to end ovarian cancer as a cause of death, and today, on #WorldOvarianCancerDay, we stand with the community doing the hard work to drive systemic change. You can support them too, by signing World Ovarian Cancer Coalition petition for ovarian cancer to be recognised as an urgent global health priority. Let’s ensure there’s #NoWomanLeftBehind: https://learn.az/6046jYEl6 #WOCD2024 AstraZeneca was not involved in the development of this petition. Reference: 1. World Ovarian Cancer Coalition. Ovarian Cancer Data Briefing. Available at: https://learn.az/6042jYElG. Accessed: May 2024.
It's Time To Act
https://worldovariancancercoalition.org
-
Severe asthma is a distinct and debilitating condition affecting 3-10% of asthma cases. Approximately 50% of severe asthma patients suffer from uncontrolled symptoms. Despite this, many patients face long delays and a difficult journey from diagnosis to disease control. We are standing with the global respiratory community to recognise the unique needs of patients with severe asthma and advocate for policy change which addresses the barriers patients currently face. Watch the full video and learn more about our call for change here: https://learn.az/6040jrqBm #WorldAsthmaDay
-
Congratulations to Pam Cheng, our EVP of Global Operations & IT and Chief Sustainability Officer, who has been recognised by TIME 100 Health as one of the leaders who most influenced global health this year. Under Pam’s leadership, we are taking bold action to tackle the climate crisis and make healthcare more sustainable. Together with partners and collaborators, we want to build a healthier future for people, society and the planet. https://learn.az/6048jdJ72 #TIME100Health
-
-
COPD, a leading cause of death, claimed 3 million lives in 2019 alone. In this STAT article, Caterina Brindicci, Senior Vice President and Global Head of Late Respiratory & Immunology at AstraZeneca, discusses the need to take a proactive approach to reduce the risk of both heart and lung events – termed cardiopulmonary risk – that people with COPD face. Featuring insights from Maria Belvisi, SVP & Head of Early R&D, Respiratory & Immunology and MeiLan Han, Chief, Pulmonary & Critical Care at the University of Michigan, the article explores the transformations in COPD care needed to advance our mission to eliminate COPD as a leading cause of death. Learn more: https://learn.az/6049jy3pt
-
Chronic kidney disease (CKD) caregivers report a loss of work hours due to treatment, with some carers providing up to 35 hours of support a week and others having to leave employment. As the prevalence of advanced CKD increases, the emotional, physical and financial challenges placed on family members and friends in the caregiver role is likely to increase. Early intervention of CKD can slow progression and help the psychological, physical and economic wellbeing of caregivers. Find out what happens when you make the change for CKD caregivers: https://learn.az/6040bCR6e #ForKidneyHealth
-
-
Although the World Health Organisation has declared an end to the global public health emergency, COVID-19 remains a concern for immunocompromised patients. Real-world evidence continues to show that these individuals remain at high risk for severe outcomes. Read more about the ongoing impact of COVID-19: https://learn.az/6044bC2Ta #ECCMID2024 #ESCMIDGlobal
-
-
As vulnerable populations may be significantly more susceptible than those who are healthy individuals to severe outcomes from viral or bacterial infections, there is a need to continue innovating scientifically, while simultaneously evolving regulatory pathways. In a new article with STAT, we explore the potential of passive immunisation, or the direct administration of infection-fighting monoclonal antibodies (mAbs). Read more. https://learn.az/6045ba2K3 #ECCMID2024
Leaving no person behind: The importance of innovation in passive immunization
https://www.statnews.com
-
Our company had a very strong start this year with substantial revenue growth of 19% in the first quarter coupled with exciting pipeline delivery. We’re looking forward to holding an Investor Day on 21 May 2024 where we will outline the evolution of our company and underscore our confidence in sustaining industry-leading growth. #AZN #WhatScienceCanDo
-
